Check out your Company Bowl for anonymous work chats.
We’re honored to be named one of TIME’s World’s Most Impactful Companies of 2026. From expanding access in resource-limited regions to investing in community programs that advance public health, this recognition reflects our commitment to delivering meaningful impact beyond our medicines. As we celebrate progress on our journey to treating the world’s most devastating diseases, we remain focused on access as a pathway to healthier futures for generations to come. Join us!
The most meaningful recognition isn't a trophy or a headline, it's the impact our people make every day. Across research, manufacturing, technology, commercial teams, and corporate functions, Gilead employees are helping advance innovations that have the potential to improve lives around the world. Along the way, that work has earned recognition from organizations that evaluate workplace experience, innovation, leadership, and culture. These recognitions belong to the people behind the science, the breakthroughs, and the progress. Explore the awards and recognitions that reflect the passion, expertise, and commitment of our teams.
17,000+ people. One shared mission: deliver for patients. From breakthrough HIV prevention to a growing pipeline of 50+ clinical-stage programs. Expanded global access. $260M+ invested in communities. This is what purpose-driven progress looks like at Gilead Sciences. What's next is now. Explore Gilead's 2025 Responsible Business and Impact Report. Explore the full story:
For more than 35 years, we’ve translated cutting-edge science into innovative solutions, advanced our commitment to achieve health equity and delivered life-changing medicines to people all over the world. Explore our newly redesigned website to see the strides we’ve made: https://www.gilead.com/ hashtag#GileadLife
In the early 2000s, Dr. Shannon Hader led the U.S. Centers for Disease Control and Prevention’s collaboration with the Zimbabwe Ministry of Health that provided tens of thousands of people with much-needed HIV care.
Lauren Huffmaster received a late-stage metastatic breast cancer (mBC) diagnosis in 2015 and soon discovered there wasn’t a lot information to help explain to her young children what she was going through.
For the third year in a row, Forbes has recognized Gilead as one of America’s #BestEmployersForWomen. At Gilead, we champion a culture where women can make a direct and meaningful impact and we offer an inclusive workplace and competitive benefits centered around wellbeing. Together, we drive innovation and further our mission to create a healthier world for all people.
This year, we’re among 42 organizations being recognized by Seramount as a Leading Inclusion Index Company. The recognition highlights the connections we foster, the opportunities we create for underrepresented groups and the sense of belonging we cultivate.
In 2017, Maria Morais started to experience severe abdominal pain before eventually undergoing gall bladder surgery. When the procedure didn’t bring her the relief she hoped for, follow-up tests showed her liver enzyme levels were abnormally high. Being a registered nurse, Maria knew something was wrong.
Dr. Summer Sitima is one of 24 siblings born to a Kenyan family in the 90s at the height of the HIV epidemic in Sub Saharan Africa. She vividly remembers the day in 1997 that she first learned one of her older sisters was living with HIV.
